Skip to main content
. 2021 Apr 15;13(8):1893. doi: 10.3390/cancers13081893

Figure 3.

Figure 3

Kaplan–Meier five-year overall survival estimates among patients who received neoadjuvant therapy (n = 88) versus patients who did not (n = 23).